PFIC1 clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 6 months to 18 years
Double blind, randomized, placebo controlled, Phase 3 study to investigate the efficacy and safety of low doses and high doses of A4250 compared to placebo in children with PFIC (deficiencies of familial intrahepatic cholestasis-1 or bile salt export pump).
San Francisco, California and other locations